Literature DB >> 9068292

Diagnosing cystic fibrosis: blood, sweat, and tears.

C Wallis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9068292      PMCID： PMC1717077          DOI： 10.1136/adc.76.2.85

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  28 in total

Review 1.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Authors:  M J Welsh; A E Smith
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

2.  Incidence and mortality rates of cystic fibrosis in Japan, 1969-1992.

Authors:  Y Imaizumi
Journal:  Am J Med Genet       Date:  1995-08-28

3.  Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.

Authors:  M Wilschanski; J Zielenski; D Markiewicz; L C Tsui; M Corey; H Levison; P R Durie
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

4.  Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis.

Authors:  K B Hammond; N L Turcios; L E Gibson
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

5.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

6.  Diagnostic criteria for cystic fibrosis in men with congenital absence of the vas deferens.

Authors:  I Durieu; F Bey-Omar; J Rollet; L Calemard; D Boggio; H Lejeune; R Gilly; Y Morel; D V Durand
Journal:  Medicine (Baltimore)       Date:  1995-01       Impact factor: 1.889

7.  Cystic fibrosis 3849+10kb C > T mutation associated with severe pulmonary disease and male fertility.

Authors:  D H Dreyfus; R Bethel; E W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

8.  Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis.

Authors:  B Stewart; J Zabner; A P Shuber; M J Welsh; P B McCray
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

9.  Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.

Authors:  P M Farrell; R E Koscik
Journal:  Pediatrics       Date:  1996-04       Impact factor: 7.124

10.  A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.

Authors:  W E Highsmith; L H Burch; Z Zhou; J C Olsen; T E Boat; A Spock; J D Gorvoy; L Quittel; K J Friedman; L M Silverman
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245
View more
  6 in total

Review 1.  Atypical cystic fibrosis--diagnostic and management dilemmas.

Authors:  Colin Wallis
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

3.  Shwachman-Diamond syndrome in a child presenting with cystic fibrosis-type symptoms and a false-positive sweat test.

Authors:  S M N Brown; R Buchdahl
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

Review 4.  Diagnosis of cystic fibrosis: Indian perspective.

Authors:  S K Kabra; G J Connett; C J Rolles
Journal:  Indian J Pediatr       Date:  1999 Nov-Dec       Impact factor: 1.967

Review 5.  Using Phecodes for Research with the Electronic Health Record: From PheWAS to PheRS.

Authors:  Lisa Bastarache
Journal:  Annu Rev Biomed Data Sci       Date:  2021-07-20

6.  Evaluation of continuous constant current and continuous pulsed current in sweat induction for cystic fibrosis diagnosis.

Authors:  Carla Cristina Souza Gomez; Fernando Augusto Lima Marson; Maria Fátima Servidoni; Antônio Fernando Ribeiro; Maria Ângela Gonçalves Oliveira Ribeiro; Veruska Acioli Lopes Gama; Eduardo Tavares Costa; José Dirceu Ribeiro; Francisco Ubaldo Vieira Junior
Journal:  BMC Pulm Med       Date:  2018-09-14       Impact factor: 3.317
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.